Metraipolis › archive › dc_448f0b52d6ea

Effectiveness of Pfizer Vaccine BNT162b2 Against SARS-CoV-2 in Americans 16 and Older: A Systematic Review — Europe PMC PMID:39171051

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39171051
DOI
10.7759/cureus.65111
License (as archived)
solo-consultazione
Archived
2026-11-01T05:26:27.931Z
SHA-256 of the archived text
c3a23ed2da5a343238a76a33058e6c94a66e16763445832a6222f71b7942a3f6
Stable URL of this page
https://metraipolis.com/documento/dc_448f0b52d6ea

How to cite

Effectiveness of Pfizer Vaccine BNT162b2 Against SARS-CoV-2 in Americans 16 and Older: A Systematic Review — Europe PMC PMID:39171051 — Europe PMC (en), https://europepmc.org/article/MED/39171051 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_448f0b52d6ea (Metraipolis archive dc_448f0b52d6ea, sha256 c3a23ed2da5a343238a76a33058e6c94a66e16763445832a6222f71b7942a3f6)
BibTeX
@misc{dc448f0b52d6ea,
  title = {Effectiveness of Pfizer Vaccine BNT162b2 Against SARS-CoV-2 in Americans 16 and Older: A Systematic Review — Europe PMC PMID:39171051},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39171051},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_448f0b52d6ea; sha256 c3a23ed2da5a343238a76a33058e6c94a66e16763445832a6222f71b7942a3f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39171051. Agents can read the archived copy with the MCP tool read_document.